Avita appoints new chairman


By Dylan Bushell-Embling
Tuesday, 20 May, 2014

Avita Medical (ASX:AVH) has appointed seasoned healthcare executive Lou Panaccio to the role of board chairman.

Panaccio has more than 30 years of experience as an executive in the healthcare and life sciences sectors, including 15 years of board experience.

He is currently non-executive director of Sonic Healthcare (ASX:SHL), executive chairman of Health Networks Australia and non-executive director of Inner East Community Health Service. Previous roles include a 10-year stint as CEO and a director of Melbourne Pathology.

Panaccio replaces Ian Macpherson, who had been serving as interim chairman since December following the resignation of long-serving chairman Dalton Gooding.

Macpherson said the board had selected Panaccio for the role because he has “a business background steeped in practical biomedical industry experience, particularly in business development and steering biotech and healthcare products from conception stages through to generating meaningful sales and revenue”.

This experience will serve the company well as it prepares to accelerate commercialisation efforts for its ReCell regenerative medicine technology, he said.

Avita Medical (ASX:AVH) shares were trading unchanged at $0.110 as of around 2 pm on Tuesday.

Related News

argenx and Monash University partner against autoimmune diseases

To advance a pioneering molecule for autoimmune diseases, global immunology company argenx has...

Archer completes potassium sensing alpha prototype

Quantum technology company Archer Materials Limited has developed an early Biochip prototype...

Farm animals and aquaculture cryopreservation partnership announced

Vitrafy Life Sciences Limited has announced that it has entered a 12-month exclusive agreement...


  • All content Copyright © 2026 Westwick-Farrow Pty Ltd